DashboardPortfoliosWatchlistCommunityDiscoverScreener
  • Community
  • /
  • United States
  • /
  • Healthcare
Author Program NEWCreate Narrative
RDNT logo

RadNet, Inc. Stock Price

NasdaqGM:RDNT Community·US$5.6b Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 14 Fair Values set on narratives written by author
Author Program NEWCreate Narrative

RDNT Share Price Performance

US$74.28
0.55 (0.75%)
​
US$92.88
Fair Value
US$74.28
0.55 (0.75%)
20.0% undervalued intrinsic discount
US$92.88
Fair Value
Price US$74.28
AnalystConsensusTarget US$92.88
AnalystLowTarget US$70.50
AnalystHighTarget US$105.00
Tue, 11 Aug 26
Fair ValueUS$92.88
Share Pricen/a

RDNT Community Narratives

AN
AnalystConsensusTarget
AnalystConsensusTarget's
Fair Value
·
Fair Value US$92.88 20.0% undervalued intrinsic discount

RDNT: Imaging Center Demand And Digital Health Will Drive Measured Upside Potential

0users have liked this narrative
0users have commented on this narrative
8users have followed this narrative
AN
AnalystLowTarget
AnalystLowTarget's
Fair Value
·
Fair Value US$70.5 5.4% overvalued intrinsic discount

Outpatient Imaging And AI Adoption Will Shape A Steady But Capped Outlook

0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
AN
AnalystHighTarget
AnalystHighTarget's
Fair Value
·
Fair Value US$105 29.3% undervalued intrinsic discount

AI And Advanced Imaging Will Drive Stronger Margins And Earnings Durability

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
RDNT logo
RadNet
20.0% undervalued intrinsic discount

RDNT: Imaging Center Demand And Digital Health Will Drive Measured Upside Potential

View narrative
AN
AnalystConsensusTarget
AnalystConsensusTarget
Updated 11 Aug
Read Narrative
RDNT logo
RadNet
29.3% undervalued intrinsic discount

AI And Advanced Imaging Will Drive Stronger Margins And Earnings Durability

View narrative
AN
AnalystHighTarget
AnalystHighTarget
Published 12 Aug
Read Narrative
RDNT logo
RadNet
5.4% overvalued intrinsic discount

Outpatient Imaging And AI Adoption Will Shape A Steady But Capped Outlook

View narrative
AN
AnalystLowTarget
AnalystLowTarget
Published 26 Aug
Read Narrative

Trending Discussion

No trending discussion available.

Recently Updated Narratives

AN
AnalystLowTarget
RDNT logo

Outpatient Imaging And AI Adoption Will Shape A Steady But Capped Outlook

Fair Value: US$70.5 5.4% overvalued intrinsic discount
1 fair value setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
AnalystHighTarget
RDNT logo

AI And Advanced Imaging Will Drive Stronger Margins And Earnings Durability

Fair Value: US$105 29.3% undervalued intrinsic discount
0 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
AnalystConsensusTarget
RDNT logo

RDNT: Imaging Expansion And Breast Ultrasound AI Clearance Will Support Earnings

Fair Value: US$92.88 20.0% undervalued intrinsic discount
8 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative

Snowflake Analysis

Good value with moderate growth potential.

2 Risks
3 Rewards
View Full Analysis

RadNet, Inc. Key Details

US$2.3b

Revenue

US$1.9b

Cost of Revenue

US$392.2m

Gross Profit

US$413.3m

Other Expenses

-US$21.1m

Earnings

Last Reported Earnings
Jun 30, 2026
Next Reporting Earnings
n/a
-0.27
17.28%
-0.93%
95.6%
View Full Analysis

About RDNT

Founded
1981
Employees
9060
CEO
Howard Berger
WebsiteView website
www.radnet.com

RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States and internationally. The company operates in two segments, Imaging Centers and Digital Health. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems that distribute, display, store, and retrieve digital images; picture archiving communications systems and related services; and develops and deploys AI suites to enhance radiologist interpretations of breast, lung, and prostate images, as well as solutions for prostate cancer screening. In addition, it develops and delivers AI-powered health informatics solutions to drive quality, efficiency, and outcomes in imaging and radiology; informatics designed for outpatient radiology; and DeepHealth OS, a cloud-native operating system that helps in the operations of the radiology service. RadNet, Inc. was founded in 1981 and is headquartered in Los Angeles, California.

Recent RDNT News & Updates

User avatar
New Narrative • Aug 26

Outpatient Imaging And AI Adoption Will Shape A Steady But Capped Outlook

Catalysts About RadNet RadNet operates outpatient imaging centers and a growing digital health segment focused on radiology AI and enterprise imaging software. What are the underlying business or industry changes driving this perspective?
User avatar
New Narrative • Aug 12

AI And Advanced Imaging Will Drive Stronger Margins And Earnings Durability

Catalysts About RadNet RadNet operates a large network of outpatient imaging centers and a growing digital health platform focused on radiology AI and enterprise imaging software. What are the underlying business or industry changes driving this perspective?

Recent updates

No updates

RadNet, Inc. Competitors

VEEV logo

Veeva Systems

Symbol: NYSE:VEEV
Market cap: US$42.2b
IDXX logo

IDEXX Laboratories

Symbol: NasdaqGS:IDXX
Market cap: US$40.6b
DXCM logo

DexCom

Symbol: NasdaqGS:DXCM
Market cap: US$31.7b
CNC logo

Centene

Symbol: NYSE:CNC
Market cap: US$31.6b
View more competitors

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide